Compounds > pentylenetetrazole
Page last updated: 2024-08-17

pentylenetetrazole and cp 465,022

pentylenetetrazole has been researched along with cp 465,022 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchan, AM; Chenard, BL; Critchett, DJ; Ganong, AH; Guanowsky, V; Menniti, FS; Seymour, PA; Welch, WM1

Other Studies

1 other study(ies) available for pentylenetetrazole and cp 465,022

ArticleYear
CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
    Stroke, 2003, Volume: 34, Issue:1

    Topics: Animals; Brain Ischemia; Hippocampus; Male; Motor Activity; Neuroprotective Agents; Pentylenetetrazole; Quinazolines; Rats; Receptors, AMPA; Seizures; Synaptic Transmission

2003